Back
Cleveland-Cliffs, Inc. Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison
Sell
45
CLF
Cleveland-Cliffs, Inc.
Last Price:
$13.41
Seasonality Move:
6.63%
Buy
61
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$117.57
Seasonality Move:
-9.01%
Sell
45
Cleveland-Cliffs, Inc. (CLF)
is a Sell
Is Cleveland-Cliffs, Inc. a Buy, Sell or Hold?
-
The current Cleveland-Cliffs, Inc. [CLF] share price is $13.41. The Score for CLF is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
CLF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Buy
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $117.62. The Score for RYTM is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CLF Stock Price Chart
What is Cleveland-Cliffs, Inc.'s stock price today?
-
The Cleveland-Cliffs, Inc. share price today is $13.41Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLF is experiencing buying pressure, which is a positive indicator for future bullish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $117.62Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight buying pressure.
CLF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 62.62 | Buy |
| Chaikin Money Flow: | 11281522 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.7 - 12.78) | Buy |
| Bollinger Bands (100): | (10.35 - 13.01) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.17 | Buy |
| Relative Strength Index (14 RSI): | 65.29 | Buy |
| Chaikin Money Flow: | 622990 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (98.54 - 107.68) | Buy |
| Bollinger Bands (100): | (93.66 - 107.58) | Buy |
CLF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.73 | Buy |
| 20-day SMA: | 12.08 | Buy |
| 50-day SMA: | 12.46 | Buy |
| 200-day SMA: | 9.95 | Buy |
| 8-day EMA: | 12.71 | Buy |
| 20-day EMA: | 12.35 | Buy |
| 50-day EMA: | 12.09 | Buy |
| 200-day EMA: | 11.14 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.58 | Buy |
| 20-day SMA: | 104.18 | Buy |
| 50-day SMA: | 104.81 | Buy |
| 200-day SMA: | 81.44 | Buy |
| 8-day EMA: | 107.12 | Buy |
| 20-day EMA: | 105.38 | Buy |
| 50-day EMA: | 103.54 | Buy |
| 200-day EMA: | 86.38 | Buy |
Cleveland-Cliffs, Inc. Earnings Growth & CLF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.59 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.72 per share, and an increase next year of $2.66 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.56 per share.
Cleveland-Cliffs, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||